Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (251-260 of 399) with videos related to

Pageof 40
Sort By:
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia & Lymphoma|June 12, 2012
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupChelsea J Gudgeon, Kimberly H Harrington, George S Laszlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Favorable impact of the t(9;11) in childhood acute myeloid leukemiaJeffrey E Rubnitz, Susana C Raimondi, Xin Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemiaT R Golub, G F Barker, S K Bohlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
British Journal of Haematology|March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
Blood|January 1, 1990
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemiaC H Pui, F G Behm, B Singh, et al.
Pageof 40

Showing results (251-260 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia & Lymphoma|June 12, 2012
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupChelsea J Gudgeon, Kimberly H Harrington, George S Laszlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Favorable impact of the t(9;11) in childhood acute myeloid leukemiaJeffrey E Rubnitz, Susana C Raimondi, Xin Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemiaT R Golub, G F Barker, S K Bohlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
British Journal of Haematology|March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
Blood|January 1, 1990
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemiaC H Pui, F G Behm, B Singh, et al.
Pageof 40